Vaccination

What's at stake in COVID-19 jab patent waiver row

Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.

Medications

India licenses generic copy of patented Bayer drug

(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.

Other

US Supreme Court rejects blood monitoring patents

Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.

Medications

India rejects Bayer plea against cheap cancer drug (Update)

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive ...

Other

Pharma lobby blasts 'stupid' pandemic patent plans

Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.

Diseases, Conditions, Syndromes

Monkeypox: The next global vaccine equity failure?

Inequitable access to COVID-19 vaccines has turned out to be the catastrophic moral failure the World Health Organization's director-general warned about at the beginning of 2021.

Vaccination

US backs plan to waive COVID-19 vaccine patents

US President Joe Biden's administration on Wednesday announced support for a global waiver on patent protections for COVID-19 vaccines, offering hope to poor nations that have struggled to access the life-saving doses.

page 1 from 2